Cannabis Report
Home > Boards > Free Zone > Health and Sciences >

Biotech Values

RSS Feed
      Hide Sticky   Hide Intro
Moderator: DewDiligence Assistants: Biowatch
Search This Board: 
Last Post: 6/24/2018 5:26:37 PM - Followers: 1393 - Board type: Free - Posts Today: 2

Biotech Values is a forum for discussing 
all facets of biotech investing with an emphasis
on fundamental analysis and avoiding scams.
We generally do not discuss microcap stocks.

Compilations
FDA Calendar
Biotech Buyouts/Premiums

Biotech Acronyms
'Way Back' Archive

Cannabis Report
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#219765  Sticky Note Re: ASMB R&D Day: mcbio 06/23/18 01:45:41 PM
#219759  Sticky Note Alexo Therapeutics—>ANX Oncology—(private CD47 company): DewDiligence 06/22/18 11:04:41 AM
#219747  Sticky Note BMY: I would bet that FDA doesn’t want JohnWayne 06/21/18 11:13:14 PM
#219740  Sticky Note Re: RVNC phase-3 CD program ...the new news DewDiligence 06/21/18 06:34:47 PM
#219727  Sticky Note TGTX > Novimmune, TG ally to take CD47-CD19 biocqr 06/21/18 11:23:12 AM
#219715  Sticky Note More on EOLS' unique business model (LOL): DewDiligence 06/20/18 07:11:43 PM
#219772   ASMB—I'm not questioning the size of the addressable DewDiligence 06/24/18 05:26:37 PM
#219771   Re: JAK inhibitors associated with increased risk of lymphoma FreeNorth 06/24/18 12:10:18 AM
#219770   ASMB - It's good for humanity that somebody mcbio 06/23/18 09:42:23 PM
#219769   ASMB—Obviously, if the true rate of decay ends DewDiligence 06/23/18 07:19:41 PM
#219768   Re: ASMB - ASBM's calculations regarding the rate mcbio 06/23/18 06:56:24 PM
#219767   Sign of market top? DewDiligence 06/23/18 06:28:55 PM
#219766   ASBM—…there's always going to be caveats in projecting DewDiligence 06/23/18 03:02:45 PM
#219765   Re: ASMB R&D Day: mcbio 06/23/18 01:45:41 PM
#219764   https://www.yahoo.com/news/alzheimer-disease-may-triggered-herpes-153525970.html Preciouslife1 06/23/18 08:57:14 AM
#219763   RVNC- “Brotox” - all good news for RVNC biotech_researcher 06/23/18 06:01:00 AM
#219762   I agree, and, while others may differ, in GrthzGd 06/22/18 04:38:40 PM
#219761   BSGM gapped up 15% EOD today. It's an GrthzGd 06/22/18 04:26:39 PM
#219760   PLI.TO touts NASH candidate: DewDiligence 06/22/18 11:08:26 AM
#219759   Alexo Therapeutics—>ANX Oncology—(private CD47 company): DewDiligence 06/22/18 11:04:41 AM
#219758   AUTL’s own IPO PR: DewDiligence 06/22/18 10:59:18 AM
#219757   SLNO ...my 5/23/18 pitch Whalatane 06/22/18 10:38:30 AM
#219756   Thanks. That makes sense. I thought randychub 06/22/18 10:36:01 AM
#219755   RVNC—For each new indication, will the FDA continue DewDiligence 06/22/18 10:34:07 AM
#219754   RVNC. For each new indication will the FDA randychub 06/22/18 10:18:31 AM
#219753   SLNO...up 38% on huge vol. Whalatane 06/22/18 09:46:39 AM
#219752   AUTL IPOs 10.12M* shares @$17.00: DewDiligence 06/22/18 09:38:58 AM
#219751   I assume they will submit both the safety DewDiligence 06/22/18 09:29:08 AM
#219750   That's a plausible explanation, IMO. DewDiligence 06/22/18 09:27:48 AM
#219749   ASMB—...the webcast is nearly 3 hours long. Did DewDiligence 06/22/18 09:26:30 AM
#219748   As they describe the phase 3 “program” there mouton29 06/22/18 08:24:37 AM
#219747   BMY: I would bet that FDA doesn’t want JohnWayne 06/21/18 11:13:14 PM
#219746   ASMB R&D Day: Scientific rationale for being able mcbio 06/21/18 10:11:40 PM
#219745   When a company is reported to be in DewDiligence 06/21/18 07:19:58 PM
#219744   Dew is the chance of a buyout greater tony111 06/21/18 07:03:20 PM
#219743   There are many, many examples, but each case DewDiligence 06/21/18 06:52:29 PM
#219742   I have a question for all the experts tony111 06/21/18 06:49:05 PM
#219741   BMY—Someone on Twitter asked (perhaps rhetorically) why this DewDiligence 06/21/18 06:43:48 PM
#219740   Re: RVNC phase-3 CD program ...the new news DewDiligence 06/21/18 06:34:47 PM
#219739   TNDM PR: DewDiligence 06/21/18 06:25:57 PM
#219738   TNDM moving up huge in AH. on FDA approval. crudeoil24 06/21/18 06:19:10 PM
#219737   It’s odd that UTSW is running a single-arm/no-biomarker DewDiligence 06/21/18 06:13:15 PM
#219736   The 24 month duration results for the phase mouton29 06/21/18 05:21:28 PM
#219735   UTSW/Merck open label, Phase 2 clinical trial involving Keytruda: north40000 06/21/18 05:06:03 PM
#219734   RVNC- Terrific results, and helps in validating that biotech_researcher 06/21/18 04:32:37 PM
#219733   BMY—Opdivo/Yervoy PDUFA in high-TMB 1L-NSCLC is 2/20/19 (with DewDiligence 06/21/18 04:29:01 PM
#219732   FDA reconsiders/withdraws its draft guidelines on biosimilars: north40000 06/21/18 04:21:47 PM
#219730   16:08 Revance doses first patient in Phase 3 jbog 06/21/18 04:18:07 PM
#219729   HRTX:PRs and SEC documents filed this morning...the gist: north40000 06/21/18 03:45:51 PM
#219728   RETA - I got a little more aggressive nowlurking 06/21/18 12:05:53 PM
#219727   TGTX > Novimmune, TG ally to take CD47-CD19 biocqr 06/21/18 11:23:12 AM
#219726   Anyone have any thoughts on how much the randychub 06/21/18 11:12:35 AM
#219725   [OT] Interesting story about why the Dow Committee GrthzGd 06/21/18 11:06:46 AM
#219724   EOLS can engage in promotional stunts other cos GrthzGd 06/21/18 10:55:00 AM
#219723   TRXC -CFO sells ~290K shares @ $4 mostly nowlurking 06/21/18 09:45:49 AM
#219722   Five biotech IPOs in 24 hours. That's the DewDiligence 06/21/18 08:52:01 AM
PostSubject